Smoking cessation interventions
Pro Research Analysisby 
Searched over 200M research papers
Smoking Cessation Interventions: Pharmacological and Non-Pharmacological Approaches
Pharmacological Interventions for Smoking Cessation
Pharmacotherapy is a well-established and effective approach for smoking cessation. Medications such as nicotine replacement therapy (NRT), bupropion, and varenicline are approved and have demonstrated significant efficacy in increasing prolonged abstinence rates compared to placebo, with varenicline often showing the highest success rates among monotherapies. Combination therapies, such as varenicline plus bupropion or NRT plus mecamylamine, are even more effective than single-drug treatments, offering the greatest probability of successful cessation. Extended use of these medications (beyond 12 weeks) further improves quit rates and reduces relapse compared to standard durations of use. Adverse events are reported but are generally not significantly different from placebo, and most side effects are mild and expected with NRT use Gaddey2022Lu2024Shang2022.
Behavioural and Non-Pharmacological Interventions
Behavioural interventions, including counselling, cognitive behavioural education, and motivational support, are effective in helping people quit smoking. Counselling and guaranteed financial incentives have the strongest evidence for increasing quit rates at six months or longer. Other promising approaches include interventions delivered via text message, quitline counselling, and tailored or interactive internet-based programs. The effectiveness of behavioural interventions can vary depending on the intensity, delivery mode, and content, but overall, they are beneficial and do not increase harm. Combining behavioural support with pharmacotherapy is more effective than either approach alone Gaddey2022Hartmann-Boyce2021Villanti2020+2 MORE.
System Change and Public Health Interventions
System change interventions—such as integrating smoking status identification and offering cessation support into routine healthcare—improve process outcomes like documentation, counselling, and referrals to quitlines. However, current evidence does not show a clear increase in long-term quit rates from these system-level changes alone. Public health strategies, including community pricing policies and peer support, also play a role, but their effectiveness is maximized when combined with individual and interpersonal interventions 4Kim2021.
Special Populations and Alternative Approaches
For young adults, interventions based on social cognitive theory, quitline counselling, and text messaging show promise for short-term cessation. There is limited evidence for pharmacological interventions in this age group. Reduction-to-quit strategies, where individuals gradually reduce smoking before quitting, are as effective as abrupt quitting, especially when aided by fast-acting NRT or varenicline. Non-nicotine e-cigarettes may help some smokers transition to less harmful alternatives, but evidence for their effectiveness in cessation is inconclusive and they are not FDA-approved for this purpose Gaddey2022Villanti2020Lindson2018+1 MORE.
Conclusion
The most effective smoking cessation interventions combine pharmacotherapy with behavioural support. Medications like varenicline, especially in combination with other therapies, and structured behavioural interventions such as counselling and financial incentives, significantly improve quit rates. System-level and public health interventions enhance the delivery and uptake of cessation support but are most effective when integrated with individual-focused strategies. For young adults and those seeking alternatives to abrupt quitting, tailored interventions and reduction-to-quit methods offer additional options. Overall, a multi-faceted approach is recommended to maximize the chances of successful smoking cessation Gaddey2022Lu2024Hartmann-Boyce2021+5 MORE.
Sources and full results
Most relevant research papers on this topic